NMD4C Announces 2023 Early Career Award Recipients
We are excited to announce the recipients of the inaugural NMD4C Early Career Awards for 2023! This annual award program introduces three new awards, celebrating excellence and contribution to the neuromuscular field by early career investigators across both clinical and basic science streams.
This year, the NMD4C awarded three Early Career Awards as a part of this program: Early Career Biomedical Researcher of the Year, Early Career Clinical Researcher of the Year, and Early Career Publication of the Year.
We would like to congratulate this year’s recipients:
Early Career Biomedical Researcher of the Year award:
Dr. Nicolas Dumont, Associate professor, Rehabilitation department, University of Montreal
Early Career Clinical Researcher of the Year award:
Dr. Cam-Tu Émilie Nguyen, Neurologist, Assistant Professor, CHU Sainte-Justine, Université de Montréal
Early Career Publication of the Year:
Dr. Farshad Babaeijandaghi, Postdoctoral Fellow, Fabio Rossi Lab, University of British Columbia
“Metabolic reprogramming of skeletal muscle by resident macrophages points to CSF1R inhibitors as muscular dystrophy therapeutics”.
By creating these awards, the NMD4C provides a method of recognizing outstanding achievement by early career neuromuscular researchers and clinicians on behalf of the Canadian neuromuscular community. Recipients receive a tangible accolade to bolster their academic CVs in pursuit of future academic appointments and grant applications. This award program is a part of the network’s broader strategy to provide support for Canadian early-career neuromuscular investigators.
“Early career investigators are at a stage in their careers where finding the funding and academic appointments to continue their research programs and clinical work is integral to their career progression in the field of neuromuscular care and research. These applications are highly competitive, and it is our hope that receiving an NMD4C award can help support and strengthen these applications to secure important research funding and academic appointments.”
- Dr. Natasha Chang, Assistant Professor, Department of Biochemistry, McGill University and NMD4C Early-Career working group member
Thank you to all those who submitted nominations for these awards; we received many strong applications, and we look forward to hosting these awards again for the coming year. More information on the application process for 2024 is available on our awards page.
Read next...
Discover Neuromuscular Talent Across Canada
The NMD4C Neuromuscular Talent Pool is now live with new trainees! We invite supervisors and research groups to explore the Talent Pool to identify candidates whose skills, experience, and interests align with your work and upcoming positions. Trainees interested in being included in the Neuromuscular Talent Pool can register by completing the short form, uploading a CV and brief personal statement outlining their experience, interests, and career goals. For more information and to access the Talent Pool, please visit our website.
Join Us at the 2026 NMD4C Annual Meeting on 25 September
The 2026 NMD4C Annual Meeting will take place in Calgary on Friday, September 25, 2026. The agenda will feature a brief network update, trainee and early-career recognitions, flash talks, a health economics research showcase, and a series of cross‑disciplinary and parallel clinical/pre‑clinical discussion sessions to explore key topics, including advocacy and therapy access, strategies to sustain and strengthen pre-clinical programs, and network sustainability and strategic planning.
Introducing Our New SOP on Skeletal Muscle Fiber Typing
We are excited to announce the release of our latest Standard Operating Procedure (SOP) titled “Skeletal Muscle Fiber Typing & Cross-Sectional Area Analysis using Immunofluorescence Staining for Mice,” developed by from our Basic Science Trainee Committee (BSTC) member Shatha Atieh, Phd Student at uOttawa. This SOP aims to provide a comprehensive, step-by-step protocol for staining and analyzing skeletal muscle fibers from any muscle group in various mouse models. This new SOP provides detailed methods for immunofluorescence‑based fiber typing using MyHC‑I, MyHC‑IIA, MyHC‑IIB, and laminin, enabling accurate assessment of fiber‑type composition and cross‑sectional area (CSA).